Related Experiment Video
Updated: Jun 22, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Pulmonary responses to polyhydroxylated fullerenols, C(60)(OH)(x)
Jing-Ying Xu1, Kaiyu Han, Shu-Xia Li
1Laboratory of Clinical Visual Sciences of Tongji Eye Institute and Department of Regenerative medicine, Tongji University School of Medicine, Shanghai, People's Republic of China.
Abstract:
Although many scientists have been attracted by polyhydroxylated fullerenols for their radical-scavenging and antioxidant ability in vivo and in vitro and their potential use as a drug or for drug delivery, there is little information on their pulmonary toxicological properties. The aim of this study was to investigate the effect of polyhydroxylated derivatives of fullerene on Sprague-Dawley rats after intratracheal instillation. Polyhydroxylated fullerenols [C(60)(OH)(x), x = 22, 24] were administered intratracheally (1, 5 or 10 mg per rat). Following 3-day exposures, the lungs of the rats were assessed using bronchoalveolar lavage fluid biomarkers and a pathological evaluation of lung tissue. Exposures to 1 mg per rat did not induce adverse pulmonary toxicity, while the two other doses induced cell injury effect, oxidative/nitrosative stress and inflammation, showing that C(60)(OH)(x) produced responses in a dose-dependent manner. The dosage of C(60)(OH)(x) retained in lung and the ensuing aggregation might be the main factor in the process. Our results might shed light on the possible use of C(60)(OH)(x) as an inhaled drug.
More Related Videos
11:26Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
Published on: June 8, 2012
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...